Literature DB >> 11796702

Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D(2) system.

Osamu Hayaishi1.   

Abstract

To elucidate the exact role of the PGD(2) system in sleep-wake regulation in vivo, the sleep behavior of knockout mice, generated in the author's and other laboratories, was examined for lipocalin-type PGD synthase (L-PGDS), PGD receptor, adenosine A(2A) receptor, and histamine H(1) receptor; transgenic mice overexpressing the human L-PGDS gene, generated in the author's laboratory, were also examined. The circadian profiles of sleep patterns of wild-type and the genetically manipulated mice were essentially identical, indicating the possibility that the deficiency of one system may be effectively compensated by some other systems during development. Available evidence indicated that the PGD(2) system is involved in the homeostatic regulation of non-rapid eye movement sleep and that the arousal effect of orexin A is mediated by the histamine H(1) receptor system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796702     DOI: 10.1152/japplphysiol.00766.2001

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Sleep-waking discharge patterns of median preoptic nucleus neurons in rats.

Authors:  Natalia Suntsova; Ronald Szymusiak; Md Noor Alam; Ruben Guzman-Marin; Dennis McGinty
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

2.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

Review 3.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

4.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

5.  CSF prostaglandin D synthase is reduced in excessive daytime sleepiness.

Authors:  Claudio L Bassetti; Martin Hersberger; Christian R Baumann
Journal:  J Neurol       Date:  2006-04-05       Impact factor: 4.849

6.  Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep.

Authors:  Akira Terao; Zhi-Li Huang; Jonathan P Wisor; Takatoshi Mochizuki; Dmitry Gerashchenko; Yoshihiro Urade; T S Kilduff
Journal:  J Neurochem       Date:  2008-03-07       Impact factor: 5.372

7.  Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: Evidence from high-density oligonucleotide arrays and in situ hybridization.

Authors:  Jessica A Mong; Nino Devidze; Donald E Frail; Lawrence T O'Connor; Manjo Samuel; Elena Choleris; Sonoko Ogawa; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

8.  Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.

Authors:  Martin Begemann; Derya Sargin; Moritz J Rossner; Claudia Bartels; Fabian Theis; Sven P Wichert; Nike Stender; Benjamin Fischer; Swetlana Sperling; Sabina Stawicki; Anne Wiedl; Peter Falkai; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

9.  Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication.

Authors:  Okay Saydam; Carlos Abril; Bernd Vogt; Mathias Ackermann; Martin Schwyzer
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.

Authors:  S Saleem; Z A Shah; Y Urade; S Doré
Journal:  Neuroscience       Date:  2009-02-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.